Particle Therapy Market Research Report – Global Forecast till 2027

Global Particle Therapy Market: Information by Type (Proton Therapy & Heavy Ion Therapy), Product & Service (Products & Others), Cancer Type (Prostate, Lung), System (Multi-Room & Single Room), Application (Treatment & Research) —  Forecast till 2027

ID: MRFR/MED/5535-HCR | February 2021 | Region: Global | 85 pages

Please note that the assessment period of report has been updated from 2018-2023 to 2020-2027. Cordially fill the sample form for updated data.

Market Scenario:


The Global Particle Therapy Market is accounted for USD 790.45 million in 2017 and expected to register 9.1% CAGR during the forecast period (2018–2023). Particle therapy is one of the world's most advanced areas of external beam radiation therapy applied to oncology. This technique saves healthier radiation tissue better than conventional photon therapy. These particles have more favorable physical intrinsic properties that reduce the intake dose to approximately 50% of the dose in a clinically relevant target.


The rising prevalence of cancer population, low risk of treatment induced disorders, potential for retreatment owing to low radiation dose, and rising number of particle therapy centers across the world are expected to drive the growth of the market. Moreover, rising R&D spending and aggressive strategies adopted by the top players such as new product launches are contributing to the growth of the market. For instance, in December 2017, Advanced Oncotherapy plc announced that it secures the fresh funding of USD 46.75 million from which USD 37.5 million of funds coming from a new Chinese investor. The lack of adequate reimbursement policy and high costs involved in the establishment of these centers may hamper the growth of the market during the assessment period.


Segmentation:


The Global Particle Therapy Market has been segmented on the basis of type, product & service, cancer type, system, and application.On the basis of type, the market has been classified as proton therapy and heavy ion therapy. The market, by product and services, has been segmented into products and services. Products are further segmented into cyclotrons, synchrotrons, and synchrocyclotrons. Based on cancer type, the market has been segmented into prostate cancer, lung cancer, pediatric cancer, head and neck cancer, breast cancer, and others. The market, by system, has been segmented into multi-room systems and single-room systems. On the basis of application, the market has been classified as treatment applications and research applications. The pediatric cancer segment is expected to hold the largest market share of the particle therapy market, by cancer type, during the forecast period. Also, research applications to register the highest CAGR in the global particle therapy market during the forecast period.


The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The particle therapy market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada. The European particle therapy market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.  The particle therapy market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The particle therapy market in the Middle East & Africa has been segmented into the Middle East and Africa.


Regional Market Summary


Global Particle Therapy Market Share, by Region, 2017 (%)


Source: MRFR Analysis


The Americas are likely to dominate the global particle therapy market owing to the rising prevalence of cancer patient, increasing funding & investments by manufacturer, and government focused for establishment of centers for treatment. According to the U.S. Department of Health and Human Services, in 2018, around 1,735,350 new cases of cancer will be diagnosed in the United States and 609,640 people will die from the disease.


The European market is expected to be the second-largest Particle Therapy market. The market growth in this region can be attributed to government funding and support of the healthcare sector coupled with increasing research and development. Moreover, favorable reimbursement policies in European countries are contributing to the growth of the market in this region.


Asia-Pacific is expected to be the fastest-growing particle therapy market during the forecast period owing to the increasing prevalence of cancer, rising investments in healthcare and expansions by market players in the region. Also, country such as India and China are considering fastest growing region due to the presence of huge patient population. Moreover, the government of these countries are open to adopt new technology, and best treatment option from a developed country. According to the International Agency for Research on Cancer, in 2018, India has a prevalence of 173.5 cancer patients per 100,000 population. Moreover, in China, the prevalence rate of cancer was 377.6 patients per 100,000 population in 2018.


The market in the Middle East & Africa is expected to account for the smallest share of the global Particle Therapy market due to an underdeveloped healthcare sector, lack of technical knowledge, and poor medical facilities.


Key Players


Some of the key players in the global particle therapy market are Advanced Oncotherapy PLC., Danfysik A/S, Hitachi, Ltd., Ion Beam Applications Sa (IBA), Mevion Medical Systems, Inc., Optivus Proton Therapy, Inc., Protom International, Inc., Provision Healthcare, LLC, Sumitomo Heavy Industries, Ltd., Varian Medical Systems, Inc.


Global Particle Therapy Market, by Type:



  • Proton Therapy

  • Heavy Ion Therapy


Global Particle Therapy Market, by Product & Service:



  • Products

    • Cyclotrons

    • Synchrotrons

    • Synchrocyclotrons



  • Services


Global Particle Therapy Market, by Cancer Type:



  • Prostate Cancer

  • Lung Cancer

  • Pediatric Cancer

  • Head and Neck Cancer

  • Breast Cancer

  • Others


Global Particle Therapy Market, by System:



  • Multi-Room Systems

  • Single-Room Systems


Global Particle Therapy Market, by Application:



  • Treatment Applications

  • Research Applications


Global Particle Therapy Market, by Region:



  • Americas

    • North America

      • US

      • Canada



    • South America



  • Europe

    • Western Europe

      • Germany

      • France

      • Italy

      • Spain

      • UK

      • Rest of Western Europe



    • Eastern Europe



  • Asia-Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Rest of Asia-Pacific



  • The Middle East & Africa

    • Middle East

    • Africa




Company Profiles:    



  • Advanced Oncotherapy PLC.

  • Danfysik A/S

  • Hitachi, Ltd.

  • Ion Beam Applications Sa (IBA)

  • Mevion Medical Systems, Inc.

  • Optivus Proton Therapy, Inc.

  • Protom International, Inc.

  • Provision Healthcare, LLC

  • Sumitomo Heavy Industries, Ltd.

  • Varian Medical Systems, Inc.

  • Others


Intended Audience:



  • Medical devices manufacturers

  • Medical devices product distributors and suppliers

  • Healthcare providers

  • Research institutes and academic centers

  • Contract manufacturing organizations

  • Government associations

  • Market research and consulting


 


 


 


 



Frequently Asked Questions (FAQ) :


The latest valuation of the particle therapy market in 2017 was USD 790.45 million.

The forecasted CAGR for the particle therapy market is 9.1% for the duration of 2018 to 2023.

The particle therapy market would be driven by factors like rising cases of cancer, an increasing number of particle therapy center, low risk of treatment, and potential retreatment opportunity can trigger better market growth.

The pediatric cancer segment has the opportunity to register the highest growth in the particle therapy market.

The Americas has the setup to continue their domination of the particle therapy market.

Table of Contents:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Global Particle Therapy Market, by Type

6.1 Introduction

6.2 Proton Therapy

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.3 Heavy Ion Therapy

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 7. Global Particle Therapy Market, by Product & Service

7.1 Introduction

7.2 Products

7.2.1 Cyclotrons

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.2.2 Synchrotrons

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.2.3 Synchrocyclotrons

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.3 Services

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 8. Global Particle Therapy Market, by Cancer Type

8.1 Introduction

8.2 Prostate Cancer

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.3 Lung Cancer

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.4 Pediatric Cancer

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.5 Head and Neck Cancer

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.6 Breast Cancer

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.7 Others

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 9. Global Particle Therapy Market, by System

9.1 Introduction

9.2 Multi-Room Systems

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

9.3 Single-Room Systems

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 10. Global Particle Therapy Market, by Application

10.1 Introduction

10.2 Treatment Applications

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

10.3 Research Applications

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 11. Global Particle Therapy Market, by Region

11.1 Introduction

11.2 Americas

11.2.1 North America

11.2.1.1 US

11.2.1.2 Canada

11.2.2 South America

11.3 Europe

11.3.1 Western Europe

11.3.1.1 Germany

11.3.1.2 France

11.3.1.3 Italy

11.3.1.4 Spain

11.3.1.5 UK

11.3.1.6 Rest of Western Europe

11.3.2 Eastern Europe

11.4 Asia-Pacific

11.4.1 Japan

11.4.2 China

11.4.3 India

11.4.4 Australia

11.4.5 South Korea

11.4.6 Rest of Asia-Pacific

11.5 Middle East & Africa

11.5.1 Middle East

11.5.2 Africa

Chapter 12. Company Landscape

12.1 Introduction

12.2 Market Share Analysis

12.3 Key Development & Strategies

Chapter 13. Company Profiles

13.1 Advanced Oncotherapy PLC.

13.1.1 Company Overview

13.1.2 Product Overview

13.1.3 Financials Overview

13.1.4 Key Developments

13.1.5 SWOT Analysis

13.2 Danfysik A/S

13.2.1 Company Overview

13.2.2 Product Overview

13.2.3 Financial Overview

13.2.4 Key Developments

13.2.5 SWOT Analysis

13.3 Hitachi, Ltd.

13.3.1 Company Overview

13.3.2 Product Overview

13.3.3 Financial Overview

13.3.4 Key Development

13.3.5 SWOT Analysis

13.4 Ion Beam Applications Sa (IBA)

13.4.1 Company Overview

13.4.2 Technologys/Business Segment Overview

13.4.3 Financial Overview

13.4.4 Key Development

13.4.5 SWOT Analysis

13.5 Mevion Medical Systems, Inc.

13.5.1 Company Overview

13.5.2 Product Overview

13.5.3 Financial overview

13.5.4 Key Developments

13.5.5 SWOT Analysis

13.6 Optivus Proton Therapy, Inc.

13.6.1 Company Overview

13.6.2 Product Overview

13.6.3 Financial Overview

13.6.4 Key Developments

13.6.5 SWOT Analysis

13.7 Protom International, Inc.

13.7.1 Overview

13.7.2 Product Overview

13.7.3 Financial Overview

13.7.4 Key Developments

13.7.5 SWOT Analysis

13.8 Provision Healthcare, LLC

13.8.1 Overview

13.8.2 Product/ Technology Overview

13.8.3 Financials

13.8.4 Key Developments

13.8.5 SWOT Analysis

13.9 Sumitomo Heavy Industries, Ltd.

13.9.1 Overview

13.9.2 Product Overview

13.9.3 Financials

13.9.4 Key Developments

13.9.5 SWOT Analysis

13.10 Varian Medical Systems, Inc.

13.10.1 Overview

13.10.2 Product Overview

13.10.3 Financials

13.10.4 Key Developments

13.10.5 SWOT Analysis

13.11 Others

Chapter 14. MRFR Conclusion

14.1 Key Findings

14.1.1 From CEO’s Viewpoint

14.1.2 Unmet Needs of the Market

14.2 Key Companies to Watch

14.3 Predictions for the Particle Therapy Industry

Chapter 15. Appendix

LIST OF TABLES

Table 1 Global Particle Therapy Market Synopsis, 2020-2027

Table 2 Global Particle Therapy Market Estimates and Forecast, 2020-2027 (USD Million)

Table 3 Global Particle Therapy Market, by Region, 2020-2027 (USD Million)

Table 4 Global Particle Therapy Market, by Type, 2020-2027 (USD Million)

Table 5 Global Particle Therapy Market, by Product & Service, 2020-2027 (USD Million)

Table 6 Global Particle Therapy Market, by Cancer Type, 2020-2027 (USD Million)

Table 7 Global Particle Therapy Market, by System, 2020-2027 (USD Million)

Table 8 Global Particle Therapy Market, by Application, 2020-2027 (USD Million)

Table 9 North America: Particle Therapy Market, by Type, 2020-2027 (USD Million)

Table 10 North America: Particle Therapy Market, by Product & Service, 2020-2027 (USD Million)

Table 11 North America: Particle Therapy Market, by Cancer Type, 2020-2027 (USD Million)

Table 12 North America: Particle Therapy Market, by System, 2020-2027 (USD Million)

Table 13 Table 9 North America: Particle Therapy Market, by Application, 2020-2027 (USD Million)

Table 14 US: Particle Therapy Market, by Type, 2020-2027 (USD Million)

Table 15 US: Particle Therapy Market, by Product & Service, 2020-2027 (USD Million)

Table 16 US: Particle Therapy Market, by Cancer Type, 2020-2027 (USD Million)

Table 17 US: Particle Therapy Market, by System, 2020-2027 (USD Million)

Table 18 US: Particle Therapy Market, by Application, 2020-2027 (USD Million)

Table 19 Canada: Particle Therapy Market,by Type, 2020-2027 (USD Million)

Table 20 Canada: Particle Therapy Market, by Product & Service, 2020-2027 (USD Million)

Table 21 Canada: Particle Therapy Market, by Cancer Type, 2020-2027 (USD Million)

Table 22 Canada: Particle Therapy Market, by System, 2020-2027 (USD Million)

Table 23 Canada: Particle Therapy Market, by Application, 2020-2027 (USD Million)

Table 24 South America: Particle Therapy Market, by Type, 2020-2027 (USD Million)

Table 25 South America: Particle Therapy Market, by Product & Service, 2020-2027 (USD Million)

Table 26 South America: Particle Therapy Market, by Cancer Type, 2020-2027 (USD Million)

Table 27 South America: Particle Therapy Market, by System, 2020-2027 (USD Million)

Table 28 South America: Particle Therapy Market, by Application, 2020-2027 (USD Million)

Table 29 Europe: Particle Therapy Market, by Type, 2020-2027 (USD Million)

Table 30 Europe: Particle Therapy Market, by Product & Service, 2020-2027 (USD Million)

Table 31 Europe: Particle Therapy Market, by Cancer Type, 2020-2027 (USD Million)

Table 32 Europe: Particle Therapy Market, by System, 2020-2027 (USD Million)

Table 33 Europe: Particle Therapy Market, by Application, 2020-2027 (USD Million)

Table 34 Western Europe: Particle Therapy Market, by Type, 2020-2027 (USD Million)

Table 35 Western Europe: Particle Therapy Market, by Product & Service, 2020-2027 (USD Million)

Table 36 Western Europe: Particle Therapy Market, by Cancer Type, 2020-2027 (USD Million)

Table 37 Western Europe: Particle Therapy Market, by System, 2020-2027 (USD Million)

Table 38 Western Europe: Particle Therapy Market, by Application, 2020-2027 (USD Million)

Table 39 Eastern Europe: Particle Therapy Market, by Type, 2020-2027 (USD Million)

Table 40 Eastern Europe: Particle Therapy Market, by Product & Service, 2020-2027 (USD Million)

Table 41 Eastern Europe: Particle Therapy Market, by Cancer Type, 2020-2027 (USD Million)

Table 42 Eastern Europe: Particle Therapy Market, by System, 2020-2027 (USD Million)

Table 43 Eastern Europe: Particle Therapy Market, by Application, 2020-2027 (USD Million)

Table 44 Asia-Pacific: Particle Therapy Market, by Type, 2020-2027 (USD Million)

Table 45 Asia-Pacific: Particle Therapy Market, by Product & Service, 2020-2027 (USD Million)

Table 46 Asia-Pacific: Particle Therapy Market, by Cancer Type, 2020-2027 (USD Million)

Table 47 Asia-Pacific: Particle Therapy Market, by System, 2020-2027 (USD Million)

Table 48 Asia-Pacific: Particle Therapy Market, by Application, 2020-2027 (USD Million)

Table 49 Middle East & Africa: Particle Therapy Market, by Type, 2020-2027 (USD Million)

Table 50 Middle East & Africa: Particle Therapy Market, by Product & Service, 2020-2027 (USD Million)

Table 51 Middle East & Africa: Particle Therapy Market, by Cancer Type, 2020-2027 (USD Million)

Table 52 Middle East & Africa: Particle Therapy Market, by System, 2020-2027 (USD Million)

Table 53 Middle East & Africa: Particle Therapy Market, by Application, 2020-2027 (USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Global Particle Therapy Market

Figure 3 Segmentation Market Dynamics for Global Particle Therapy Market

Figure 4 Global Particle Therapy Market Share, by Type, 2020

Figure 5 Global Particle Therapy Market Share, by Product & Service, 2020

Figure 6 Global Particle Therapy Market Share, by Cancer Type, 2020

Figure 7 Global Particle Therapy Market Share, by System, 2020

Figure 8 Global Particle Therapy Market Share, by Application, 2020

Figure 9 Global Particle Therapy Market Share, by Region, 2020

Figure 10 North America: Particle Therapy Market Share, by Country, 2020

Figure 11 Europe: Particle Therapy Market Share, by Country, 2020

Figure 12 Asia-Pacific: Particle Therapy Market Share, by Country, 2020

Figure 13 Middle East & Africa: Particle Therapy Market Share, by Region, 2020

Figure 14 Global Particle Therapy Market: Company Share Analysis, 2020 (%)

Figure 15 Advanced Oncotherapy PLC.: Key Financials

Figure 16 Advanced Oncotherapy PLC.: Segmental Revenue

Figure 17 Advanced Oncotherapy PLC.: Geographical Revenue

Figure 18 Danfysik A/S: Key Financials

Figure 19 Danfysik A/S: Segmental Revenue

Figure 20 Danfysik A/S: Geographical Revenue

Figure 21 Hitachi, Ltd.: Key Financials

Figure 22 Hitachi, Ltd.: Segmental Revenue

Figure 23 Hitachi, Ltd.: Geographical Revenue

Figure 24 Ion Beam Applications Sa (IBA): Key Financials

Figure 25 Ion Beam Applications Sa (IBA): Segmental Revenue

Figure 26 Ion Beam Applications Sa (IBA): Geographical Revenue

Figure 27 Mevion Medical Systems, Inc.: Key Financials

Figure 28 Mevion Medical Systems, Inc.: Segmental Revenue

Figure 29 Mevion Medical Systems, Inc.: Geographical Revenue

Figure 30 Optivus Proton Therapy, Inc.: Key Financials

Figure 31 Optivus Proton Therapy, Inc.: Segmental Revenue

Figure 32 Optivus Proton Therapy, Inc.: Geographical Revenue

Figure 33 Protom International, Inc.: Key Financials

Figure 34 Protom International, Inc.: Segmental Revenue

Figure 35 Protom International, Inc.: Geographical Revenue

Figure 36 Provision Healthcare, LLC: Key Financials

Figure 37 Provision Healthcare, LLC: Segmental Revenue

Figure 38 Provision Healthcare, LLC: Geographical Revenue

Figure 39 Sumitomo Heavy Industries, Ltd.: Key Financials

Figure 40 Sumitomo Heavy Industries, Ltd.: Segmental Revenue

Figure 41 Sumitomo Heavy Industries, Ltd.: Geographical Revenue

Figure 42 Varian Medical Systems, Inc.: Key Financials

Figure 43 Varian Medical Systems, Inc.: Segmental Revenue

Figure 44 Varian Medical Systems, Inc.: Geographical Revenue